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Variation in quantitative gene expression has been observed in natural populations and
associated with various complex traits/phenotypes such as risks for common diseases
and drug response. MicroRNAs (miRNAs), a family of small, non-coding RNA molecules,
have been demonstrated to be an important class of gene regulators that mostly down-
regulate gene expression at the post-transcriptional level. A comprehensive and reliable
catalogue of miRNAs and miRNA gene targets is critical to understanding the gene regula-
tory networks.Though experimental approaches have been used to identify many miRNAs
and their gene targets, due to cost and efﬁciency, currently miRNA and target identiﬁ-
cation still largely relies on computational algorithms. We reviewed several widely used
bioinformatic resources of miRNA sequences and gene targets that take advantage of the
unique characteristics of miRNA–mRNA interactions, experimental validation, as well as
the integration of sequence-based evidence and microarray expression data. Furthermore,
given the importance of miRNAs in regulating gene expression, elucidating expression
quantitative trait loci involved with miRSNPs or miR-polymorphisms will help improve our
understanding of complex traits. We reviewed the available resources of miRNA genetic
variation, and the current progress (e.g., the 1000 Genomes Project) in detailing the genetic
variation in miRNA-related single nucleotide polymorphisms (SNPs).We also provided our
perspectives of the potential impact of next-generation sequencing on the research of
miRNAs, gene targets, and miRSNPs. These bioinformatic resources may help interpret
experimental and association study results, thus enhancing our knowledge of the dynamic
gene regulatory networks and the physiological pathways for complex traits/phenotypes.
Prospectively, these bioinformatic resources ofmiRNAswill need to address the challenges
raised by the application of next-generation sequencing in miRNA research.
Keywords: microRNA, gene expression, gene regulation, genetic variation, single nucleotide polymorphism,
RNA-sequencing
INTRODUCTION
Alterations in gene expression,a quantitative phenotype,have been
implicated in a variety of human diseases and traits, as well as
response to therapeutic treatments (Zhang and Dolan, 2009). The
variation of gene expression, therefore, could potentially explain
the phenotypic variations (e.g., susceptibility to complex diseases,
and drug response) among individuals and human populations.
For example, differentially expressed genes enriched in ubiqui-
tin proteasome and Parkinson’s disease pathways were found
be associated with coffee consumption, a model for addictive
behavior (Amin et al., 2011). In contrast, based on a cell-based
pharmacogenomic discovery model using the HapMap Project
(HapMap, 2003, 2005) lymphoblastoid cell line (LCL) samples,
whole-genome gene expression proﬁling (i.e., transcriptome pro-
ﬁling; Zhang et al., 2008, 2009) has allowed identiﬁcation of gene
expression phenotypes associated with the cytoxicities to anti-
cancer drugs, such as etoposide (Huang et al., 2007a), daunoru-
bicin (Huang et al., 2008a), carboplatin (Huang et al., 2008b),
cisplatin (Huang et al., 2007b), andAra-C (cytarabine arabinoside;
Hartford et al., 2009). In addition, signiﬁcant variation in gene
expression has been observed among individuals from the same
human population, as well as among individuals from different
ethnic background (Cheung et al., 2003a,b; Stranger et al., 2005,
2007a,b; Spielman et al., 2007; Storey et al., 2007; Duan et al.,
2008; Zhang et al., 2008). For example, a substantial proportion of
human genes (e.g., genes related to immune response) have been
found to be differentially expressed between individuals of African
and Northern/Western European ancestry (Zhang et al., 2008).
Particularly, common genetic variants including single nucleotide
polymorphisms (SNPs) and copy number variants (CNVs) have
been identiﬁed to contribute to the variation in gene expres-
sion (e.g., through expression quantitative trait loci, eQTLs) both
within and between human populations (Cheung et al., 2003a,b;
Stranger et al., 2005, 2007a,b; Spielman et al., 2007; Storey et al.,
2007; Duan et al., 2008; Zhang et al., 2008). Besides genetic factors,
non-genetic factors such as environmental exposure, life style, diet
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may play at least as great a role as genetic divergence inmodulating
gene expression variation in humans (Idaghdour et al., 2008).
During the past decade, epigenetic mechanisms (e.g., DNA
methylation, histone modiﬁcations) have begun to be appreci-
ated as playing critical roles in regulating gene expression, and
affecting complex traits including risks for common diseases.
Recent process in biomedical research emphasizes the need to
move beyond protein-coding genes and highlights the fact that
continued investigation of non-coding RNAs (ncRNAs) will be
necessary for a comprehensive understanding of human traits and
diseases (Taft et al., 2010;Kaikkonen et al., 2011). Notably,microR-
NAs (miRNAs), a family of small, ncRNAs molecules, have been
demonstrated to be an important class of gene regulators that
mostly downregulate gene expression at the post-transcriptional
level (Ambros, 2001; Bartel, 2004). Dysregulation of miRNAs and
some other ncRNAs is being found to have relevance to tumori-
genesis, neurological, cardiovascular, developmental, respiratory,
and other diseases, as well as individual response to drugs (Zhang
and Dolan, 2010; Esteller, 2011; Zhou et al., 2011). For exam-
ple, dysregulation of miRNAs in brains has been observed after
exposure to addictive drugs like cocaine (Eipper-Mains et al.,
2011),while upregulation of somemiRNAs have been identiﬁed in
human alcoholics (Lewohl et al., 2011). In addition, pharmacoge-
nomic studies have related miRNAs as an important mechanism
for regulating genes responsible for drug response (Zhang and
Dolan, 2010; Huang et al., 2011). A comprehensive understand-
ing of miRNAs and other functional ncRNAs will be necessary
for future integration of various “omics” data for elucidating
the underpinning mechanisms of complex diseases, phenotypes,
and traits including the fundamental problem of gene expression
regulation.
Given the critical roles of miRNAs in gene regulation and
human diseases, it is imperative to have a comprehensive and reli-
able catalog of miRNA sequences (e.g., mature miRNAs, pre-, and
pri-miRNAs) and miRNA gene targets. In addition to experimen-
tal approaches, computational algorithms have been developed for
predicting miRNA sequences and their potential gene targets. To
allow user-friendly queries, there are publicly available, web-based
resources for miRNA sequences and gene targets. The current
bioinformatic resources of miRNAs provide miRNA sequences
and their gene targets from both experimental approaches and
computational algorithms (in silico predictions). Furthermore,
SNPs within the sequences of human miRNAs and their gene
targets have been shown to have impact on various phenotypes
and diseases such as cancer, blood pressure, and drug resistance
(Mishra et al., 2007; Sethupathy et al., 2007; Landi et al., 2008).
The polymorphisms in miRNA (miRSNPs) appear to have a dif-
fering effect on gene and protein expression, thus representing a
novel type of genetic variation that may inﬂuence complex traits
such as the risks of certain humandiseases (Chen et al., 2008).With
the advances in genotyping and sequencing technologies, genetic
variation data on miRSNPs have become available for analyses
in elucidating the mechanisms of miRNAs and complex phe-
notypes/traits. Therefore, we reviewed several publicly available
miRNA-related (particularly, in humans) bioinformatic resources
that accommodate miRNA sequences, miRNA gene targets, and
miRSNPs (Table 1). Prospectively, these bioinformatic resources
of miRNAs will need to address the challenges raised by the
emerging applications of novel technologies (e.g., next-generation
sequencing) in miRNA research.
miRBASE – A DATABASE OF miRNA SEQUENCES
Since its launch as theMicroRNA Registry (Grifﬁths-Jones, 2004),
themiRBase database1 (Grifﬁths-Jones,2004;Grifﬁths-Jones et al.,
2006, 2008; Kozomara and Grifﬁths-Jones, 2011) has evolved into
a central portal for miRNA sequences and other relevant informa-
tion. The miRBase is a searchable database of published mature
miRNA sequences, together with their predicted source hairpin
precursors and annotations relating to their discovery, structure,
and function (Grifﬁths-Jones et al., 2006). The miRBase contains
miRNA sequence information from two fundamentally differ-
ent sources: (1) experimentally veriﬁed mature miRNAs; and (2)
miRNA sequences that are predicted homologs of miRNAs veri-
ﬁed in a related organism (Grifﬁths-Jones et al., 2006). Each entry
1http://www.mirbase.org/
Table 1 | Some widely used bioinformatic resources of microRNA sequences, gene targets and genetic variation.
Contents Database Data source/type of evidence URL
MicroRNA sequences miRBase Computational prediction, sequencing,
and experimental veriﬁcation
http://www.mirbase.org/
Ensemble Comprehensive genome browser http://www.ensembl.org/
UCSC genome browser Comprehensive genome browser http://genome.ucsc.edu/
MicroRNA targets MicroCosm Computational prediction http://www.ebi.ac.uk/enright-srv/microcosm/
TargetScan http://www.targetscan.org/
PicTar http://pictar.mdc-berlin.de/
ExprTarget Computational prediction and
microarray
http://www.scandb.org/apps/microrna/
miRDB http://mirdb.org/
microRNA.org http://www.microrna.org/
TarBase Experimental validation http://diana.cslab.ece.ntua.gr/tarbase/
miRecords Comprehensive database http://mirecords.biolead.org/
MicroRNA variation miRvar Literature http://genome.igib.res.in/mirlovd/
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in the miRBase database represents a predicted hairpin portion of
a miRNA transcript (termed“mir” in the database), with informa-
tion on the location and sequence of the mature miRNA sequence
(termed “miR”; Ambros et al., 2003).
The current miRBase Release 18 (November, 2011) contains
18,226 entries representing hairpin precursor miRNAs, express-
ing 21,643 mature miRNA products, in 168 species. Particularly,
there are 1,527 human miRNA sequences provided bythe miR-
Base (accessed on December 1, 2011). The miRBase also provides
links of miRNAs to potential gene targets predicted by Micro-
Cosm, TargetScan (Lewis et al., 2003), and PicTar (Krek et al.,
2005), which are described in the following section. Both hairpin
and mature sequences are available for searching and brows-
ing, and entries can also be retrieved by name (e.g., “let-7” or
“miR-36”), keyword (e.g. “human”), references, and annotation.
Queries can also be performed by genomic location, tissue expres-
sion (e.g., adenosquamous cell, embryonic stem cell for humans)
and sequence. For searches by sequence, users can perform either
BLASTN or SSEARCH to search against the intact precursor
sequences or just the mature miRNAs. All sequence and anno-
tation data served at the miRBase are also available for bulk
download. In addition, novel miRNA sequences can be submitted
to miRBase by researchers, therefore, the miRBase acts as a cen-
tral depository of miRNA sequences. Besides themiRBase website,
other major genome databases such as the Ensemble2 and UCSC
GenomeBrowser3 (Kent et al., 2002) also provide access tomiRNA
sequences and annotations. For example, the Ensemble Genome
Browser can be used to obtain miRNA sequences that have been
predicted by BLASTN of genomic sequence slices against miRBase
sequences (Guttman et al., 2009).
RESOURCES OF miRNA GENE TARGETS
Given the critical roles of miRNAs in regulating gene expression
and cellular functions, a comprehensive and reliable catalog of
miRNA gene targets will beneﬁt the biomedical research commu-
nity, for example, by enabling the construction of gene regulatory
networks, as well as gene-set or pathway-based analyses. Though
molecular biology approaches may be used to experimentally
determine gene targets for miRNAs, the lack of high throughput
techniques and the relatively high cost associated with experi-
mental approaches limit their use in identifying all of miRNA
gene targets. Therefore, to date, only some gene targets of a small
number of the potential >1000 human miRNAs have been con-
ﬁrmed experimentally.Anothermajor challengewithmiRNAgene
target identiﬁcation is that an individual miRNA may regulate
multiple mRNAs, and in contrast, an individual gene may also
be regulated by multiple miRNAs, thus representing a complex
network of miRNA–mRNA interactions. In lieu of experimental
approaches, several computational approaches have been devel-
oped for genome-wide prediction of miRNAgene targets by taking
advantage of the properties of miRNAs’ binding to gene targets.
In animals, miRNAs typically bind to the 3′-UTRs (untranslated
regions) of their target mRNAs to form miRNA–mRNA duplexes,
leading to regulatory repression of translation (Lai et al., 2004),
2http://www.ensembl.org/
3http://genome.ucsc.edu/
although the exact mechanism is not completely clear. Therefore,
these approaches commonly depend on either miRNA–mRNA
complementarity: e.g., miRanda (Enright et al., 2003; Grifﬁths-
Jones et al., 2008), TargetScan (Lewis et al., 2003), or miRNA–
mRNA duplex thermodynamics: e.g., PicTar (Krek et al., 2005).
Notably, pair-wise comparisons of the miRanda scores (Enright
et al., 2003; Grifﬁths-Jones et al., 2008), PicTar scores (Krek et al.,
2005), andTargetScan scores (Lewis et al., 2003)were performed to
evaluate the correlations between these computational algorithms
(Gamazon et al., 2010). In general, these computational algo-
rithms appeared to generate a signiﬁcant number of overlapping
miRNA gene targets between each pair of algorithms (Gama-
zon et al., 2010): 21,590 between miRanda (Enright et al., 2003;
Grifﬁths-Jones et al., 2008) and TargetScan (Lewis et al., 2003),
2,465 betweenmiRanda (Enright et al., 2003; Grifﬁths-Jones et al.,
2008) and PicTar (Krek et al., 2005), as well as 8,707 between Tar-
getScan (Lewis et al., 2003) and PicTar (Krek et al., 2005). Using
TarBase (Papadopoulos et al., 2009), a database of experimentally
supported miRNA targets, as gold standard, an receiver operat-
ing characteristic (ROC) analysis on each of the above-mentioned
computational algorithms would seem to suggest that TargetScan
(Lewis et al., 2003) may yield slightly better performance than the
other computational methods (Gamazon et al., 2010). Recently,
with the availability of whole-genomemicroarraydata,approaches
that aim to integrate both microarray data and sequence-based
evidence have also been proposed to predict miRNA targets (e.g.,
ExprTarget; Gamazon et al., 2010). However, caution must be
exercised in the interpretation of these results, given each predic-
tion approach may be biased toward particular characteristics of
miRNA–mRNA interactions, possibly a reason why some of these
approaches may not provide consistent predictions. For example,
since gene expression can be tissue-speciﬁc, results from inte-
grative approaches utilizing both sequence-based evidence and
microarray data, therefore, could be biased toward genes expressed
in a particular tissue (e.g., the LCLs). Regarding bioinformatic
resources, there are several widely used web-based databases that
provide access to those computationally predicted miRNA gene
targets, experimentally supportedmiRNAgene targets andmiRNA
gene targets derived from integrated approaches.
MICROCOSM TARGETS
The MicroCosm Targets is a web resource (formerly the miRBase
Targets)4 containing computationally predicted targets for miR-
NAs across many species including humans. The current Version
5 database contains detected relationships for 851 human miR-
NAs and ∼35,000 transcripts (accessed on December 1, 2011).
The miRNA sequences were from the miRBase; Grifﬁths-Jones,
2004; Grifﬁths-Jones et al., 2006, 2008; Kozomara and Grifﬁths-
Jones, 2011) and most genomic sequences from Ensembl (see
text footnote 2). The miRanda algorithm (Enright et al., 2003;
Grifﬁths-Jones et al., 2008) was used to identify potential bind-
ing sites for a given miRNA in genomic sequences. Particularly,
the current Version 5 of the MicroCosm Targets database used
dynamic programming alignment to identify highly complemen-
tary miRNA–mRNA pairs which are scored between 0 (i.e., no
4http://www.ebi.ac.uk/enright-srv/microcosm/
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complementarity) and 100 (i.e., complete complementarity). The
miRanda algorithm (Enright et al., 2003; Grifﬁths-Jones et al.,
2008) uses a weighted scoring system and rewards complementar-
ity at the 5′ end of miRNA. P-values are also calculated following
statistical model proposed by Rehmsmeier et al. (2004). Since
miRanda requires strict complementarity at the seed region (i.e.,
the 5′ end of miRNA) of miRNA–mRNA pairs, this algorithm
does not allow alignments where more than one base in the seed
region is not complementary to a targetmRNA. Furthermore, gene
targets selected by miRanda (Enright et al., 2003; Grifﬁths-Jones
et al., 2008) were passed through theVienna RNA folding routines
(Hofacker, 2003; Gruber et al., 2008) for evaluating the property
of thermodynamic stability. MicroCosm Targets supports queries
for individualmiRNAs, individual genes, gene ontology (GO;Ash-
burner et al., 2000) classes (e.g., cellular component, biological
process) in a selected genome (e.g., the human genome), as well as
batch queries. The MicroCosm Targets supports bulk download
of the complete dataset.
TARGETSCAN
TargetScan5 (Lewis et al., 2003) is a web resource that provided
computationally predicted miRNA gene targets by searching for
the presence of conserved 8 and 7 mer sites that match the seed
region of each miRNA for a variety of species. TargetScanHuman
(Release 6.0, November, 2011) is a sub-database for predicting
human miRNA gene targets based on the TargetScan approach
(Lewis et al., 2003). The current TargetScanHuman Release 6.0
contains ∼18,000 mRNAs, corresponding to ∼30,000 transcripts
(accessed on December 1, 2011). As an option, TargetScanHu-
man also provides non-conserved sites and sites with mismatches
in the seed region that are compensated by conserved 3′ pairing
(i.e., conserved 3′-compensatory sites; Friedman et al., 2009). The
TargetScan predictions are ranked based on the predicted efﬁcacy
of targeting (Grimson et al., 2007; Garcia et al., 2011) and by
their probability of conserved targeting (i.e., PCT; Friedman et al.,
2009), which reﬂects the Bayesian estimate of the probability that
a site is conserved due to selective maintenance of miRNA tar-
geting rather than by chance or any other reason not pertinent
to miRNA targeting. TargetScan supports bulk download of the
complete dataset.
PICTAR
PicTar6 (Krek et al., 2005), a searchable website provides details
(e.g., 3′-UTR alignments with computationally predicted sites,
links to various public databases) of human miRNA targets that
are not conserved but co-expressed (i.e., the miRNA and mRNA
expressed in the same tissue; Chen and Rajewsky, 2006), as well
as miRNA target predictions in vertebrates (Krek et al., 2005),
Drosophila (Grun et al., 2005), and nematode species (Lall et al.,
2006). PicTar (Krek et al., 2005) uses a probabilistic model to com-
pute the likelihood that sequences are miRNA target sites when
compared to the 3′-UTR background. In vivo experimental vali-
dation suggests a high degree of accuracy and sensitivity for the
PicTar algorithm in ﬂies (Stark et al., 2005). PicTar (Krek et al.,
5http://www.targetscan.org/
6http://pictar.mdc-berlin.de/
2005) supports queries and bulk download for more than 13,000
co-expressed human microRNA target predictions (Chen and
Rajewsky, 2006) between 31 unique human miRNAs and ∼5,000
transcripts in multiple tissues (accessed on December 1, 2011).
TARBASE
In contrast to those databases for computationally predicted
miRNA gene targets, TarBase7 (Papadopoulos et al., 2009) v5.0
(accessed onDecember 1, 2011) houses amanually curated collec-
tion of more than 1,300 experimentally supported miRNA target
interactions in a variety of species including human, mouse, and
several other model organisms. TarBase (Papadopoulos et al.,
2009) supports queries for individual miRNAs and genes in a
selected organism. For humans, the current v5.0 database contains
1,094 miRNA–mRNA relationships (>100 miRNAs and ∼900
transcripts) that are supported by experimental evidence. For each
miRNA–mRNA relationship, TarBase (Papadopoulos et al., 2009)
provides the type of experimental support (e.g., microarray, pSI-
LAC – pulsed stable isotope labeling by amino acids), detailed
information on miRNA and mRNA target, as well as the scientiﬁc
references.
EXPRTARGET
The efﬁcacy of computational approaches to locate and rank
potential genomic binding sites is supported by the relatively high
degree of miRNA complementarity to experimentally determined
binding sites (Maziere and Enright, 2007). In contrast, ExprTar-
get8 (Gamazon et al., 2010) provides a comprehensive catalog of
miRNA targets supported by both sequence-based evidence and
microarray gene expression association. Particularly, ExprTarget
(Gamazon et al., 2010) combines miRNA (Huang et al., 2011) and
exon array expression data (Zhang et al., 2009; mRNA-level) on
117 unrelated HapMap CEU (Caucasians from Utah, USA) and
YRI (Yoruba people from Ibadan,Nigeria) LCL samples, thus pro-
viding an expression-corroborated catalog of miRNA targets (225
expressed miRNAs in LCLs and∼9,000 transcripts) that were also
predicted using the miRanda algorithm (Ambros, 2001; Enright
et al., 2003; Grifﬁths-Jones et al., 2008). ExprTarget (Gamazon
et al., 2010) will be expanded to accommodate miRNA target
predictions in other human tissues such as liver.
miRDB
miRDB9 (Wang, 2008;Wang and El Naqa, 2008), is an online data-
base for predicted miRNA targets in animals using an algorithm
called MirTarget2, which was developed by analyzing thousands
of genes impacted by miRNAs with an support vector machine
(SVM) algorithm and a microarray training dataset. Particularly,
by systematically analyzing publicmicroarray data, statistically sig-
niﬁcant features that are important to gene target downregulation
were identiﬁed (Wang andElNaqa,2008). For humanmiRNAs, the
currentmiRDB v4.0 (accessed on January 10, 2012) contains 1,919
miRNAs and more than >16,000 unique gene targets. About half
of the predicted human miRNA target sites are not conserved in
7http://diana.cslab.ece.ntua.gr/tarbase/
8http://www.scandb.org/apps/microrna/
9http://mirdb.org/
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other organisms (Wang, 2008; Wang and El Naqa, 2008). MirTar-
get2 has been validated with independent experimental data for its
improved performance on predictingmiRNAdownregulated gene
targets (Wang and El Naqa, 2008). miRDB (Wang, 2008;Wang and
El Naqa, 2008) supports queries for individual targets or miRNAs,
as well as bulk download of the complete dataset.
microRNA.org
The microRNA.org website10 (John et al., 2004; Landgraf et al.,
2007; Betel et al., 2008) is a comprehensive resource of miRNA
target predictions, target downregulation scores, and experimen-
tally observed expression patterns. Particularly, themicroRNA.org
target predictions are based on a development of the miRanda
algorithm (Enright et al., 2003; Grifﬁths-Jones et al., 2008), which
incorporates current biological knowledge on target rules and on
the use of a compendium of mammalian miRNAs. The miRNA
expression proﬁles were derived from a comprehensive sequencing
project of mammalian tissues and cell lines of normal and disease
origin (John et al., 2004; Landgraf et al., 2007; Betel et al., 2008).
The current version of the microRNA.org database (released in
August, 2010) contains predicted interactions between 249 human
miRNAs andmore than 19,000 human genes (accessed onDecem-
ber 1, 2011). The microRNA.org miRNA target predictions and
expression data (John et al., 2004; Landgraf et al., 2007; Betel et al.,
2008) are also available as tab-delimited ﬁles for bulk downloads.
miRECORDS
miRecords11 (Xiao et al., 2009) is a comprehensive resource for
animal miRNA–mRNA interactions from some of the above-
mentioned algorithms and experimental approaches. miRecords
(Xiao et al., 2009) consists of two components: (1) Validated Tar-
gets component – a large, high-quality database of experimentally
validated miRNA targets resulting from manual literature cura-
tion; and (2) The Predicted Targets component – an integration of
predicted miRNA targets produced by some established miRNA
target prediction programs: e.g., miRanda (Enright et al., 2003;
Grifﬁths-Jones et al., 2008) and TargetScan (Lewis et al., 2003).
miRecords (Xiao et al., 2009) allows queries of individual miR-
NAs in a selected organism. The search results provide detailed
evidence for miRNA–mRNA interactions from a variety of algo-
rithms and databases. The current Validated Targets component
of miRecords (Xiao et al., 2009; released in November, 2010) hosts
the interactions between 384 miRNAs and more than 1,000 target
genes in nine animal species. miRecords (Xiao et al., 2009) sup-
ports bulk download of the complete list of validated gene targets
collected in the database.
MiRSNPs – NOVEL PLAYERS IN COMPLEX TRAITS
Genomic variations including germ line or somatic mutations
may count for miRNA abnormal expression by altering their
biogenesis and/or affect the ability of miRNAs to bind to their
target mRNAs. For example, aberrant allele frequencies of the
SNPs located in miRNA target sites were found to be potentially
associated with human diseases (e.g., cancer; Yu et al., 2007; Landi
10http://www.microrna.org/
11http://mirecords.biolead.org/
et al., 2008). With the availability of comprehensive genetic vari-
ation data: e.g., the International HapMap Project (HapMap,
2003, 2005) and the 1000 Genomes Project (1000 Genomes
Consortium, 2010) genotypic data, studies of miRSNPs or miR-
polymorphisms have begun to shed novel light to the distribution
and potential biological/clinical implication of these polymor-
phisms. For example, using the HapMap Phase 1/2 genotypic
data (HapMap, 2003, 2005) on the CEU and YRI, a genome-
scale search for the regulatory polymorphisms in the loci of
pre-miRNAs and their gene targets demonstrated 187 SNPs in
the pre-miRNAs, 497 consensus SNPs in the seed-matching 3-
UTR of target genes, 385 CNVs harboring pre-miRNA precursors
and 9 CNVs covering important miRNA processing genes (Duan
et al., 2009), indicating potential roles of miR-polymorphisms in
regulating miRNAs and their gene targets. Future studies that
take advantage of more comprehensive genotypic data such as
those from the 1000 Genomes Project (1000 Genomes Con-
sortium, 2010) and other sequencing efforts will help generate
a more comprehensive list of miR-polymorphisms, thus facili-
tating future association studies between the genetic polymor-
phisms in miRNA targets/pre-miRNAs and disease susceptibility
or therapeutic outcome.
Since the researchofmiRSNPs is a relatively newﬁeld inmiRNA
research, especially relative to the research of miRNA gene tar-
gets, currently there are few bioinformatic tools or resources that
speciﬁcally devote to miRSNPs. Efforts such as the miRvar data-
base (Bhartiya et al., 2011) may prove valuable to the miRNA
research community for integrating this important type of genetic
variation in biomedical research.
miRVAR – A DATABASE FOR GENOMIC VARIATIONS IN miRNAs
miRvar12 (Bhartiya et al., 2011) is a comprehensive database for
genomic variations in miRNAs. This database contains curated
genetic variations in miRNA loci in the human genome. Particu-
larly, the miRNA genetic variation data is made available on the
Leiden Open (source) Variation Database (LOVD) platform to
provide ease of aggregation and analysis. For each genetic vari-
ant in a particular miRNA,miRvar (Bhartiya et al., 2011) provides
detailed information and links to other publicly available resources
such asmiRBase (Grifﬁths-Jones, 2004; Grifﬁths-Jones et al., 2006,
2008; Kozomara andGrifﬁths-Jones, 2011),miRecords (Xiao et al.,
2009), UCSC Genome Browser (Kent et al., 2002). In addition,
miRvar (Bhartiya et al., 2011) is open for community curation
efforts.
CONCLUSION
Since the discovery of miRNAs a decade ago, signiﬁcant progress
has been made in identifying both miRNAs and their gene tar-
gets. A number of bioinformatic resources of miRNAs have
emerged to accommodate the needs for the miRNA research
community. Given the unique properties of these small ncRNA
molecules, in addition to experimental approaches, the identiﬁ-
cation of miRNAs and their gene targets have substantially relied
upon computational and systems biology approaches. The cur-
rent bioinformatic resources of miRNAs have greatly facilitated
12http://genome.igib.res.in/mirlovd/
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the research of miRNAs and their gene targets, as well as
the integration of miRNAs into other “omics” (e.g., transcrip-
tomics, proteomics, metabolomics) studies in elucidating the net-
works of complex phenotypes (e.g., gene expression, individual
response to drugs) as well as the pathogenesis of human dis-
eases. However, a big challenge facing these current bioinformatic
resources is the integration of various resources, not only with the
miRNA resources (e.g., the miRNA gene target prediction data-
bases/approaches), but also with other relevant resources to facil-
itate the next stage of systems biomedicine research. For example,
the integration of miRNA prediction databases with the Phar-
mGKB13 (McDonagh et al., 2011), which provides the published
genetic variants implicated in drug response, may help eluci-
date the role of the interactions between genetic and non-genetic
factors (e.g., epigenetic factors including miRNAs) in determin-
ing individual drug response, thus facilitating the realization of
personalized medical care.
The current knowledge of miRNA and their interactions
with gene targets have been largely uncovered by experimental
approaches, microarray-based studies, and computational algo-
rithms. During the past several years, with the advancement of the
next-generation sequencing technologies (e.g., the IlluminaHiSeq
Sequencing System,Roche 454 GS System;Mardis, 2008), it is now
possible to perform RNA-sequencing to comprehensively catalog
miRNAs in cells under various phenotypic contexts or disease
statuses, thus enhancing our knowledge of the distribution, abun-
dance and roles of miRNAs in real-time cellular environments.
For example, deep sequencing platforms have revealed unexpected
complexity in relation to miRNAs, including 5′ and 3′-end-length
heterogeneity and RNA editing (Vaz et al., 2012). Notably, the
majority of the evidence supporting miRNA annotations are now
coming from deep sequencing experiments, as recorded in the
miRbase (Kozomara and Grifﬁths-Jones, 2011). Though analysis
13http://www.pharmgkb.org/
tools such as miRDeep (Friedlander et al., 2008) have facilitated
the current miRNA-targeted sequencing studies (Dhahbi et al.,
2011), however, challenges remain to be addressed for properly
analyzing these data, particularly the difﬁculties in aligning short
reads from RNA-sequencing projects to proﬁle miRNAs in vari-
ous cellular environments, as well as distinguishing true miRNAs
from fragments of other transcripts (Kozomara and Grifﬁths-
Jones, 2011). The availability of these large-scale sequencing data,
therefore, underscores the importance of data analysis tools and
bioinformatic resources that enable users to efﬁciently analyze the
unprecedented amounts of RNA-sequencing data. Notably, bioin-
formatic tools such as deepBase14 (Yang et al., 2010) have begun to
emergewith the ambitious attempt to provide a universal platform
for mapping, storage, retrieval, analysis, integration, annotation,
mining and visualization of next-generation sequencing data on
small and long ncRNAs including miRNAs. In addition, new
research resources such as the Sanger Institute mirKO (Prosser
et al., 2011), a library of mouse embryonic stem cell clones with
deletions for the “majority” of known miRNAs may prove to be
invaluable for the rigorous investigation of miRNA function. Fur-
thermore, data from sequencing efforts such as the 1000 Genomes
Project (1000 Genomes Consortium, 2010) may greatly improve
our understanding of miRSNPs and their potential contribution
to complex phenotypes/traits. Given the fast-evolving technolo-
gies in the general biomedical research, future development of
bioinformatic resources of miRNAs would need to address signif-
icant challenges that remain to be met for better integration and
utilization of these tremendous resources for the beneﬁt of the
miRNA research community.
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